240 related articles for article (PubMed ID: 31076013)
1. Growth differentiation factor 15: A novel biomarker with high clinical potential.
Desmedt S; Desmedt V; De Vos L; Delanghe JR; Speeckaert R; Speeckaert MM
Crit Rev Clin Lab Sci; 2019 Aug; 56(5):333-350. PubMed ID: 31076013
[TBL] [Abstract][Full Text] [Related]
2. The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1.
Unsicker K; Spittau B; Krieglstein K
Cytokine Growth Factor Rev; 2013 Aug; 24(4):373-84. PubMed ID: 23787157
[TBL] [Abstract][Full Text] [Related]
3. Coping With Stress: The Mitokine GDF-15 as a Biomarker of COVID-19 Severity.
Ahmed DS; Isnard S; Berini C; Lin J; Routy JP; Royston L
Front Immunol; 2022; 13():820350. PubMed ID: 35251002
[TBL] [Abstract][Full Text] [Related]
4. Growth Differentiation Factor-15 Orchestrates Inflammation-Related Diseases via Macrophage Polarization.
Huang J; Ding X; Dong Y; Zhu H
Discov Med; 2024 Feb; 36(181):248-255. PubMed ID: 38409830
[TBL] [Abstract][Full Text] [Related]
5. Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.
Mimeault M; Batra SK
J Cell Physiol; 2010 Sep; 224(3):626-35. PubMed ID: 20578239
[TBL] [Abstract][Full Text] [Related]
6. The clinical impact of growth differentiation factor-15 in heart disease: A 2019 update.
Arkoumani M; Papadopoulou-Marketou N; Nicolaides NC; Kanaka-Gantenbein C; Tentolouris N; Papassotiriou I
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):114-125. PubMed ID: 31663791
[TBL] [Abstract][Full Text] [Related]
7. Stress-induced growth-differentiation factor 15 plays an intriguing role in cardiovascular diseases.
Liu HT; Wang HC; Tao L; Li CX; Li F; Zhang YY; Liu BW
Chin Med J (Engl); 2013 Apr; 126(7):1350-4. PubMed ID: 23557570
[TBL] [Abstract][Full Text] [Related]
8. Diabetes mellitus related biomarker: The predictive role of growth-differentiation factor-15.
Berezin AE
Diabetes Metab Syndr; 2016; 10(1 Suppl 1):S154-7. PubMed ID: 26482961
[TBL] [Abstract][Full Text] [Related]
9. [Effects of growth differentiation factor-15 (GDF-15) on neurological systems, cardiovascular diseases, and cancer progression].
Liu DD; Mei YA
Sheng Li Xue Bao; 2017 Feb; 69(1):109-121. PubMed ID: 28217814
[TBL] [Abstract][Full Text] [Related]
10. Growth/differentiation factor-15: prostate cancer suppressor or promoter?
Vaňhara P; Hampl A; Kozubík A; Souček K
Prostate Cancer Prostatic Dis; 2012 Dec; 15(4):320-8. PubMed ID: 22370725
[TBL] [Abstract][Full Text] [Related]
11. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
[TBL] [Abstract][Full Text] [Related]
12. GDF-15, a future therapeutic target of glucolipid metabolic disorders and cardiovascular disease.
Xiao QA; He Q; Zeng J; Xia X
Biomed Pharmacother; 2022 Feb; 146():112582. PubMed ID: 34959119
[TBL] [Abstract][Full Text] [Related]
13. Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint.
Wischhusen J; Melero I; Fridman WH
Front Immunol; 2020; 11():951. PubMed ID: 32508832
[TBL] [Abstract][Full Text] [Related]
14. The divergent roles of growth differentiation factor-15 (GDF-15) in benign and malignant skin pathologies.
Ünal B; Alan S; Başsorgun Cİ; Karakaş AA; Elpek GÖ; Çiftçioğlu MA
Arch Dermatol Res; 2015 Sep; 307(7):551-7. PubMed ID: 25690161
[TBL] [Abstract][Full Text] [Related]
15. GDF-15 in Pulmonary and Critical Care Medicine.
Verhamme FM; Freeman CM; Brusselle GG; Bracke KR; Curtis JL
Am J Respir Cell Mol Biol; 2019 Jun; 60(6):621-628. PubMed ID: 30633545
[TBL] [Abstract][Full Text] [Related]
16. GDF-15 as a Target and Biomarker for Diabetes and Cardiovascular Diseases: A Translational Prospective.
Adela R; Banerjee SK
J Diabetes Res; 2015; 2015():490842. PubMed ID: 26273671
[TBL] [Abstract][Full Text] [Related]
17. Growth/differentiation factor-15/macrophage inhibitory cytokine-1 is a novel trophic factor for midbrain dopaminergic neurons in vivo.
Strelau J; Sullivan A; Böttner M; Lingor P; Falkenstein E; Suter-Crazzolara C; Galter D; Jaszai J; Krieglstein K; Unsicker K
J Neurosci; 2000 Dec; 20(23):8597-603. PubMed ID: 11102463
[TBL] [Abstract][Full Text] [Related]
18. Emerging Roles of Growth Differentiation Factor 15 in Immunoregulation and Pathogenesis.
Reyes J; Yap GS
J Immunol; 2023 Jan; 210(1):5-11. PubMed ID: 36542831
[TBL] [Abstract][Full Text] [Related]
19. Growth differentiation factor 15 is positively associated with incidence of diabetes mellitus: the Malmö Diet and Cancer-Cardiovascular Cohort.
Bao X; Borné Y; Muhammad IF; Nilsson J; Lind L; Melander O; Niu K; Orho-Melander M; Engström G
Diabetologia; 2019 Jan; 62(1):78-86. PubMed ID: 30350239
[TBL] [Abstract][Full Text] [Related]
20. Growth differentiation factor-15/macrophage inhibitory cytokine-1 induction after kidney and lung injury.
Zimmers TA; Jin X; Hsiao EC; McGrath SA; Esquela AF; Koniaris LG
Shock; 2005 Jun; 23(6):543-8. PubMed ID: 15897808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
